BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 21765081)

  • 1. Clinical applications of DNA vaccines: current progress.
    Ferraro B; Morrow MP; Hutnick NA; Shin TH; Lucke CE; Weiner DB
    Clin Infect Dis; 2011 Aug; 53(3):296-302. PubMed ID: 21765081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant formulations and delivery systems for DNA vaccines.
    Sasaki S; Takeshita F; Xin KQ; Ishii N; Okuda K
    Methods; 2003 Nov; 31(3):243-54. PubMed ID: 14511957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA vaccine strategies: candidates for immune modulation and immunization regimens.
    Doria-Rose NA; Haigwood NL
    Methods; 2003 Nov; 31(3):207-16. PubMed ID: 14511953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA vaccines--challenges in delivery.
    Pachuk CJ; McCallus DE; Weiner DB; Satishchandran C
    Curr Opin Mol Ther; 2000 Apr; 2(2):188-98. PubMed ID: 11249641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent advances on HIV DNA vaccines development: Stepwise improvements to clinical trials.
    Rezaei T; Khalili S; Baradaran B; Mosafer J; Rezaei S; Mokhtarzadeh A; de la Guardia M
    J Control Release; 2019 Dec; 316():116-137. PubMed ID: 31669566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA vaccination: antigen presentation and the induction of immunity.
    Shedlock DJ; Weiner DB
    J Leukoc Biol; 2000 Dec; 68(6):793-806. PubMed ID: 11129646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advancement in Polymer-based Carrier for DNA Vaccine.
    Goyal P; Malviya R
    Curr Pharm Des; 2023; 29(26):2062-2077. PubMed ID: 37644794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The swine CD81 enhances E2-based DNA vaccination against classical swine fever.
    Li W; Mao L; Zhou B; Liu X; Yang L; Zhang W; Jiang J
    Vaccine; 2015 Jul; 33(30):3542-8. PubMed ID: 26051512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Technical and regulatory hurdles for DNA vaccines.
    Donnelly J; Berry K; Ulmer JB
    Int J Parasitol; 2003 May; 33(5-6):457-67. PubMed ID: 12782047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The hemagglutinin-neuraminidase gene of Newcastle Disease Virus: a powerful molecular adjuvant for DNA anti-tumor vaccination.
    Ni J; Schirrmacher V; Fournier P
    Vaccine; 2010 Oct; 28(42):6891-900. PubMed ID: 20709006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microparticles and nanoparticles as delivery systems for DNA vaccines.
    Cui Z; Mumper RJ
    Crit Rev Ther Drug Carrier Syst; 2003; 20(2-3):103-37. PubMed ID: 14584521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current status of DNA vaccines and their route of administration.
    Alpar HO; Bramwell VW
    Crit Rev Ther Drug Carrier Syst; 2002; 19(4-5):307-83. PubMed ID: 12661697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD63-Mediated Antigen Delivery into Extracellular Vesicles via DNA Vaccination Results in Robust CD8
    Kanuma T; Yamamoto T; Kobiyama K; Moriishi E; Masuta Y; Kusakabe T; Ozasa K; Kuroda E; Jounai N; Ishii KJ
    J Immunol; 2017 Jun; 198(12):4707-4715. PubMed ID: 28507029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemical adjuvants for plasmid DNA vaccines.
    Greenland JR; Letvin NL
    Vaccine; 2007 May; 25(19):3731-41. PubMed ID: 17350735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advancements in DNA vaccine vectors, non-mechanical delivery methods, and molecular adjuvants to increase immunogenicity.
    Suschak JJ; Williams JA; Schmaljohn CS
    Hum Vaccin Immunother; 2017 Dec; 13(12):2837-2848. PubMed ID: 28604157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using Plasmids as DNA Vaccines for Infectious Diseases.
    Tregoning JS; Kinnear E
    Microbiol Spectr; 2014 Dec; 2(6):. PubMed ID: 26104452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multivalent TB vaccines targeting the esx gene family generate potent and broad cell-mediated immune responses superior to BCG.
    Villarreal DO; Walters J; Laddy DJ; Yan J; Weiner DB
    Hum Vaccin Immunother; 2014; 10(8):2188-98. PubMed ID: 25424922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular Adjuvants for DNA Vaccines: Application, Design, Preparation, and Formulation.
    Sabbaghi A; Ghaemi A
    Methods Mol Biol; 2021; 2197():87-112. PubMed ID: 32827133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA vaccines for targeting bacterial infections.
    Ingolotti M; Kawalekar O; Shedlock DJ; Muthumani K; Weiner DB
    Expert Rev Vaccines; 2010 Jul; 9(7):747-63. PubMed ID: 20624048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent developments in mucosal delivery of pDNA vaccines.
    Barnes AG; Barnfield C; Brew R; Klavinskis LS
    Curr Opin Mol Ther; 2000 Feb; 2(1):87-93. PubMed ID: 11249656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.